News
COEP
1.690
-5.06%
-0.090
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 1d ago
NBRV, JNCE and ALIM among healthcare movers
Seeking Alpha · 1d ago
IOVA, MQ and ONCS are among pre market gainers
Seeking Alpha · 2d ago
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 02/09 21:31
BRIEF-Coeptis Therapeutics And ShareIntel Enter Shareholder Service Agreement To Target Illegal Short Selling
Reuters · 02/07 13:12
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 02/07 13:06
Coeptis Therapeutics Partners With University of Pittsburgh to Advance Cell Therapy Development in Oncology
Coeptis Therapeutics Partners With University of Pittsburgh to Advance Cell Therapy Development in Oncology
MT Newswires · 01/31 11:50
Coeptis Therapeutics Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From NASDAQ
Benzinga · 12/29/2022 20:38
Coeptis Therapeutics Receives Non-Compliance Notice From Nasdaq
Coeptis Therapeutics Receives Non-Compliance Notice From Nasdaq
MT Newswires · 12/29/2022 16:26
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 12/19/2022 21:31
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Benzinga · 12/19/2022 11:13
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Benzinga · 12/13/2022 15:01
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Benzinga · 12/12/2022 15:01
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 11/29/2022 21:32
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 11/29/2022 16:47
US Stocks Edge Higher Following Monday's Sell-Off
Benzinga · 11/29/2022 16:03
BRIEF-Coeptis Therapeutics Engages Iqvia To Support Snap-Car Development Program
Reuters · 11/22/2022 12:20
More
Webull provides a variety of real-time COEP stock news. You can receive the latest news about Coeptis Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About COEP
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on developing cell therapy platforms for cancer. The Company's product portfolio and rights are highlighted by a universal, multi-antigen chimeric antigen receptor (CAR)-T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK) and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells (a type of immune cell) are genetically engineered to recognize cancer cells to target and destroy them. Its CAR T therapies are revolutionizing the treatment of many blood cancers, including B cell leukemias and lymphomas by targeting specific proteins found in these cancers.